Differential binding cell-SELEX: method for identification of cell specific aptamers using high throughput sequencing

Aptamers have in recent years emerged as a viable alternative to antibodies. High-throughput sequencing (HTS) has revolutionized aptamer research by increasing the number of reads from a few (using Sanger sequencing) to millions (using an HTS approach). Despite the availability and advantages of HTS compared to Sanger sequencing, there are only 50 aptamer HTS sequencing samples available on public databases. HTS data in aptamer research are primarily used to compare sequence enrichment between subsequent selection cycles. This approach does not take full advantage of HTS because the enrichment of sequences during selection can be due to inefficient negative selection when using live cells. Here, we present a differential binding cell-SELEX (systematic evolution of ligands by exponential enrichment) workflow that adapts the FASTAptamer toolbox and bioinformatics tool edgeR, which are primarily used for functional genomics, to achieve more informative metrics about the selection process. We propose a fast and practical high-throughput aptamer identification method to be used with the cell-SELEX technique to increase the aptamer selection rate against live cells. The feasibility of our approach is demonstrated by performing aptamer selection against a clear cell renal cell carcinoma (ccRCC) RCC-MF cell line using the RC-124 cell line from healthy kidney tissue for negative selection.

[1]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[2]  Khalid K. Alam,et al.  Poly-Target Selection Identifies Broad-Spectrum RNA Aptamers , 2018, bioRxiv.

[3]  John G. Bruno,et al.  Aptamers in the Therapeutics and Diagnostics Pipelines , 2018, Theranostics.

[4]  James O McNamara,et al.  Cell-internalization SELEX: method for identifying cell-internalizing RNA aptamers for delivering siRNAs to target cells. , 2015, Methods in molecular biology.

[5]  Rolf Backofen,et al.  AptaSUITE: A Full-Featured Bioinformatics Framework for the Comprehensive Analysis of Aptamers from HT-SELEX Experiments , 2018, Molecular therapy. Nucleic acids.

[6]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[7]  Ying-Fon Chang,et al.  Tenascin-C Aptamers Are Generated Using Tumor Cells and Purified Protein* , 2001, The Journal of Biological Chemistry.

[8]  Michael Zuker,et al.  Mfold web server for nucleic acid folding and hybridization prediction , 2003, Nucleic Acids Res..

[9]  H. Ulrich,et al.  Aptamers: novelty tools for cancer biology , 2018, Oncotarget.

[10]  Thomas Werner,et al.  Next generation sequencing in functional genomics , 2010, Briefings Bioinform..

[11]  J. Rossi,et al.  Aptamers as targeted therapeutics: current potential and challenges , 2016, Nature Reviews Drug Discovery.

[12]  J. Lis,et al.  New Technologies Provide Quantum Changes in the Scale, Speed, and Success of SELEX Methods and Aptamer Characterization , 2014, Molecular therapy. Nucleic acids.

[13]  D. Shangguan,et al.  Development of DNA aptamers using Cell-SELEX , 2010, Nature Protocols.

[14]  Parashar Dhapola,et al.  QuadBase2: web server for multiplexed guanine quadruplex mining and visualization , 2016, Nucleic Acids Res..

[15]  Yue Zhao,et al.  Inferring Binding Energies from Selected Binding Sites , 2009, PLoS Comput. Biol..

[16]  J. Szostak,et al.  In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.

[17]  Michael Famulok,et al.  Fluorescence-activated cell sorting for aptamer SELEX with cell mixtures , 2010, Nature Protocols.

[18]  Khalid K. Alam,et al.  FASTAptamer: A Bioinformatic Toolkit for High-throughput Sequence Analysis of Combinatorial Selections , 2015, Molecular therapy. Nucleic acids.

[19]  Peter Dalgaard,et al.  R Development Core Team (2010): R: A language and environment for statistical computing , 2010 .

[20]  Yuri Kotliarov,et al.  Assessment of Variability in the SOMAscan Assay , 2017, Scientific Reports.

[21]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[22]  Jørgen Kjems,et al.  Characterisation of aptamer–target interactions by branched selection and high-throughput sequencing of SELEX pools , 2015, Nucleic acids research.

[23]  David R. Kelley,et al.  Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks , 2012, Nature Protocols.

[24]  Renan Valieris,et al.  Bioconda: sustainable and comprehensive software distribution for the life sciences , 2018, Nature Methods.

[25]  J. Moffat,et al.  Efficient generation of patient-matched malignant and normal primary cell cultures from clear cell renal cell carcinoma patients: clinically relevant models for research and personalized medicine , 2016, BMC Cancer.

[26]  Marcel Martin.  Cutadapt removes adapter sequences from high-throughput sequencing reads , 2011 .

[27]  I. Pabinger,et al.  A new measure for in vivo thrombin activity in comparison with in vitro thrombin generation potential in patients with hyper- and hypocoagulability , 2016, Clinical and Experimental Medicine.

[28]  John C. Chaput,et al.  Analysis of aptamer discovery and technology , 2017 .

[29]  Ryan T. Strachan,et al.  Conformationally Selective RNA Aptamers Allosterically Modulate the β2-Adrenoceptor , 2016, Nature chemical biology.

[30]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[31]  John G. Bruno,et al.  Simple Methods and Rational Design for Enhancing Aptamer Sensitivity and Specificity , 2018, Front. Mol. Biosci..

[32]  Phuong Dao,et al.  Large scale analysis of the mutational landscape in HT-SELEX improves aptamer discovery , 2015, Nucleic acids research.